Tel Aviv University researchers used CRISPR to cut the SOX2 gene from head and neck cancer cells, eliminating 50% of tumors in mice. The study, published in Advanced Science, highlights CRISPR’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback